VESNUA
Trademark domain | |
name | is free? |
---|---|
vesnua.com |
The "VESNUA" trademark, serial number 78209024 , was filed on 30th of January 2003 with a mark drawing code of 1000 and its transaction date is 78209024. The attorney assigned is Jane Ungaro, attorney docket number . Since 31st of December 2009, the document can be found in the M70 law office in the publication and issue section. The employee responsible is MARTIN, JENNIFER MCGAR and the date it was published for opposition on 09/16/2003. The date when we last checked the status of this trademark was 12/10/2006.
The "VESNUA" trademark, serial number 78937508 , was filed on 26th of July 2006 with a mark drawing code of 4000 and its transaction date is 78937508. The attorney assigned is Katrina Edge, attorney docket number VESNUA. Since 4th of May 2010, the document can be found in the M50 law office in the publication and issue section. The employee responsible is HWANG, JOHN C B and the date it was published for opposition on 01/09/2007. The date when we last checked the status of this trademark was 05/03/2010.
Other trademarks by this attorney include , ARROSOF , EMBRAZA . The corresponded responsible for this trademark is Katrina Edge, located at PFIZER INC., 150 E 42ND ST, NEW YORK NY 10017-5612.The state or country where the trademark was organized is NY by Pfizer Inc.. The legal entity type behing it is a Corporation, located at 235 East 42nd Street, New York, NY zip 10017.Other trademarks by this applicant: VENVEON.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 07/31/2006 |
Primary Code | 005 |
Goods codes | |
GS0051 | Pharmaceutical preparations for the treatment of gynecological diseases and disorders, cardiovascular diseases and disorders; central nervous system and neurological diseases and disorders; urological diseases and disorders; gastrointestinal diseases and disorders; musculoskeletal diseases and disorders; migraines, pain, inflammation and inflammatory diseases and disorders; metabolic diseases and disorders; respiratory and infectious diseases and disorders; immunological, bacterial, viral and fungal diseases and disorders; psychiatric diseases and disorders; allergies; diabetes; obesity; stroke, erectile and sexual dysfunction; and hemolytic diseases and disorders; pharmaceutical preparations, namely, osteoporosis preparations, oncological preparations, dermatological preparations, ophthalmologic preparations; smoking cessation preparations, tissue and skin repair preparations |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
04/09/2008 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
03/05/2008 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
11/03/2006 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
11/03/2006 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
11/03/2006 | EXAMINERS AMENDMENT E-MAILED | F - First Action | GNEA - EXAMINERS AMENDMENT E-MAILED | |
11/03/2006 | EXAMINERS AMENDMENT -WRITTEN | R - Renewal | CNEA - EXAMINERS AMENDMENT -WRITTEN | |
11/02/2006 | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Z - Deletion | ZZZX - PREVIOUS ALLOWANCE COUNT WITHDRAWN | |
05/03/2010 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
05/03/2010 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
10/07/2009 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
10/02/2009 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
10/02/2009 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
04/16/2009 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
04/03/2009 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
04/15/2009 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
04/03/2009 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
10/02/2008 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
09/30/2008 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
10/02/2008 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
09/30/2008 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
03/25/2008 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
09/25/2007 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
09/25/2007 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
09/25/2007 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
04/03/2007 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
01/09/2007 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
12/20/2006 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
11/21/2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
11/09/2006 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
10/02/2006 | WITHDRAWN FROM PUB - OG REVIEW QUERY | Z - Deletion | PBCR | |
09/12/2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
09/08/2006 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
09/05/2006 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
08/24/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
07/31/2006 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
The "VESNUA" trademark, serial number 77818151 , was filed on 2nd of September 2009 with a mark drawing code of 4000 and its transaction date is 77818151. The attorney assigned is Katrina Edge, attorney docket number VESNUA. Since 22nd of January 2010, the document can be found in the M80 law office in the publication and issue section. The employee responsible is BULLOFF, TOBY ELLEN and the date it was published for opposition on 12/08/2009. The date when we last checked the status of this trademark was 12/08/2009.
Other trademarks by this attorney include , ARROSOF , EMBRAZA . The corresponded responsible for this trademark is KATRINA EDGE, located at PFIZER INC., 150 E 42ND ST, NEW YORK, NY 10017-5612.The state or country where the trademark was organized is NY by Pfizer Inc.. The legal entity type behing it is a Corporation, located at 235 East 42nd Street, New York, NY zip 10017.
GOODS AND/OR SERVICES | |
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
---|---|
U.S. Class | 052 - Detergents and Soaps |
Class Status | 6 - Active |
Status Date | 09/08/2009 |
Primary Code | 005 |
Goods codes | |
GS0051 | Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines |
PROSECUTION HISTORY | ||||
Date | Description | Type | Code | |
---|---|---|---|---|
12/08/2009 | NOTICE OF PUBLICATION E-MAILED | E | NPUB - NOTICE OF PUBLICATION | |
12/08/2009 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
11/02/2009 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
11/02/2009 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
10/16/2009 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
10/14/2009 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
09/08/2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
09/05/2009 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.